NIAID

The NIAID is a component of the National Institutes of Health (NIH), the primary federal agency for conducting and supporting basic, clinical and translational medical research.

Health News from Medical News Today

Dr. Fauci wasn't involved with the study, but NIAID was a sponsor of the research.

Leprosy Linked to Armadillos

News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at www. niaid.nih.gov.

Antimicrobial Resistance: 8 Large NIH Trials Seek To Preserve The Usefulness Of Antibiotics

With these new contracts, NIAID now supports a total of eight large clinical trials in this arena.

Antimicrobial Resistance: 8 Large NIH Trials Seek To Preserve The Usefulness Of Antibiotics

NIAID conducts and supports research -- at NIH, throughout the United States, and worldwide -- to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses.

Antimicrobial Resistance: 8 Large NIH Trials Seek To Preserve The Usefulness Of Antibiotics

"Many infectious diseases are increasingly difficult to treat because bacteria and other microbes have developed resistance to commonly used antimicrobial drugs," says NIAID Director Anthony S. Fauci, M.D.

Antimicrobial Resistance: 8 Large NIH Trials Seek To Preserve The Usefulness Of Antibiotics

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced four new contracts for large-scale clinical trials that address the problem of antimicrobial resistance.

Antimicrobial Resistance: 8 Large NIH Trials Seek To Preserve The Usefulness Of Antibiotics

Like the four large NIAID trials already in progress, the four new studies are designed to answer specific questions about how to improve treatment strategies.

Antimicrobial Resistance: 8 Large NIH Trials Seek To Preserve The Usefulness Of Antibiotics

These new trials are part of a two-pronged NIAID approach to antimicrobial research: learning how to make better use of the drugs we have today in order to protect their usefulness while simultaneously facilitating the development of new drugs.

Antimicrobial Resistance: 8 Large NIH Trials Seek To Preserve The Usefulness Of Antibiotics

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced four new contracts for large-scale clinical trials ...

Antimicrobial Resistance: 8 Large NIH Trials Seek To Preserve The Usefulness Of Antibiotics